Lecture 18 Notes: Immunoprecipitation and Endocytosis
Expected Learning Outcomes (ELOs) for Lecture 18
- Understand how immunoprecipitations work and what this can tell you about protein-protein interactions.
- Describe the path an ingested molecule takes as it enters the cell via endocytosis.
- Analyze data that led to the discovery of receptor-mediated endocytosis.
ELO 1: Understanding Immunoprecipitation (IP)
- Immunoprecipitation (IP): A technique used to purify a specific protein by binding an antibody to it.
- Add a suitable antibody specific to the target protein.
- Antibody binds to the protein of interest.
- Add Protein A or G to form insoluble antibody-protein complexes.
- Centrifuge the solution to pellet the antibody-protein complex and remove supernatant for further analysis.
- Co-Immunoprecipitation (Co-IP):
- Used to purify a specific protein and detect its binding partners.
- Controls for Co-IP include:
- Check both target proteins are present in the whole cell lysate (WCL).
- Ensure the immunoprecipitated complex contains both proteins being studied.
- Use an irrelevant antibody as a control to confirm no non-specific binding occurs.
- Example of Co-IP use: Identifying the GTPase Ran and its binding partner RhoA, predicting that if Ran is immunoprecipitated, its GAP should also co-immunoprecipitate.
ELO 2: Pathway of Molecules Entering the Cell via Endocytosis
- Endocytosis: Process by which cells take in molecules by engulfing them with the plasma membrane.
- Main types of endocytosis:
- Phagocytosis: Cell takes in large solid particles (e.g., cellular eating by immune cells).
- Involves pseudopodia and formation of large vesicles (phagosomes).
- Phagosomes fuse with lysosomes for degradation.
- Pinocytosis: Cellular intake of fluids and small solutes (cellular drinking).
- Creates smaller vesicles (<150 nm).
- Receptor-mediated endocytosis (RME):
- A targeted form of pinocytosis that uses receptor proteins to selectively accumulate molecules (ligands).
- Often involves clathrin-coated vesicles that help transport substances into the cell.
- Endosomal Pathway Overview:
- External molecules bind to receptors on the cell surface.
- The plasma membrane invaginates and forms an endocytic vesicle.
- The vesicle matures into early endosome, then late endosome, and eventually fuses with lysosomes for digestion.
- RME Discovery: Research by Brown and Goldstein on familial hypercholesterolemia (FH) revealed mechanistic insights into cholesterol uptake.
- Key Findings:
- FH patients have high LDL levels due to faulty receptors responsible for LDL uptake, leading to heart disease.
- LDL regulates cholesterol synthesis in cells, impacting the balance between endogenous and exogenous sources of cholesterol.
- Research Steps:
- Established that normal cells reduce cholesterol biosynthesis in the presence of LDL.
- In FH cells, the synthesis of cholesterol remains unregulated, indicating a defect in the receptor pathway for LDL uptake.
- Hypothesis Testing: Examining the binding of labeled LDL to cells differentiated between normal and FH cells, confirming the deficiency in binding in FH cells.
Questions for Review
Based on ELO 1:
- What is immunoprecipitation, and what is its purpose?
- What does it mean when two proteins immunoprecipitate together?
- What are good controls to use in IP experiments?
- Can you deduce conclusions from given IP data?
Based on ELO 2:
- Compare phagocytosis, pinocytosis, and receptor-mediated endocytosis.
- List the pathway taken by an internalized molecule in an endosome/phagosome.
- Differentiate between early and late endosomes.
- Describe the structure and function of lysosomes.
- How is the low pH of lysosomes maintained?
- What is receptor recycling?
- How do lysosomal proteins reach lysosomes, and why don’t they degrade there?
Based on ELO 3:
- What is the primary symptom of patients with familial hypercholesterolemia (FH)?
- Describe cholesterol biosynthesis in normal cells and FH cells in the absence and presence of LDL.
- What data did Brown and Goldstein find about cholesterol metabolism in normal vs. FH individuals?